ProPhase Labs, Inc. — Investor Relations & Filings
Filings indexed
646
across all filing types
Latest filing
2026-03-27
Regulatory Filings
Country
US
United States of America
Listing
US
PRPH
ProPhase Labs, Inc. is a diversified biotechnology, genomics, and diagnostics company focused on developing, manufacturing, and commercializing health and wellness solutions. The company operates CLIA-certified laboratories to provide diagnostic and genomics testing services for healthcare providers and consumers. In addition to its diagnostics and genomics operations, ProPhase Labs offers contract manufacturing services and develops dietary supplements and other consumer health products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| NT 10-K | 2026-03-27 | English | |
| 8-K Filing | 2026-02-13 | English | |
| 8-K Filing | 2026-02-13 | English | |
| 8-K Filing | 2026-01-27 | English | |
| 8-K Filing | 2026-01-23 | English | |
| 25-NSE Filing | 2026-01-23 | English |
Browse filings by year
31 years- 2026 10 filings
- 2025 59 filings
- 2024 36 filings
- 2023 39 filings
- 2022 42 filings
- 2021 40 filings
- 2020 40 filings
- 2019 22 filings
- 2018 35 filings
- 2017 50 filings
- 2016 12 filings
- 2015 43 filings
- 2014 31 filings
- 2013 25 filings
- 2012 28 filings
- 2011 52 filings
- 2010 37 filings
- 2009 13 filings
- 2008 3 filings
- 2007 1 filing
- 2006 4 filings
- 2005 3 filings
- 2004 4 filings
- 2003 6 filings
- 2002 1 filing
- 2001 2 filings
- 2000 1 filing
- 1999 1 filing
- 1998 2 filings
- 1997 2 filings
- 1996 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 46143913 | NT 10-K | 2026-03-27 | English | ||
| 24582559 | 8-K Filing | 2026-02-13 | English | ||
| 24582327 | 8-K Filing | 2026-02-13 | English | ||
| 24582500 | 8-K Filing | 2026-01-27 | English | ||
| 24582489 | 8-K Filing | 2026-01-23 | English | ||
| 24582381 | 25-NSE Filing | 2026-01-23 | English | ||
| 24582321 | 8-K Filing | 2026-01-23 | English | ||
| 24582531 | 8-K Filing | 2026-01-09 | English | ||
| 24582304 | 8-K Filing | 2026-01-09 | English | ||
| 24582445 | 8-K Filing | 2026-01-02 | English | ||
|
2025
5 filings
| |||||
| 24582444 | 424B5 Filing | 2025-12-29 | English | ||
| 24582537 | 424B5 Filing | 2025-12-19 | English | ||
| 24582263 | 8-K Filing | 2025-12-19 | English | ||
| 24582233 | 8-K Filing | 2025-12-19 | English | ||
| 24582614 | 8-K/A Filing | 2025-12-18 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
ProPhase Labs, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34999/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34999 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34999 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34999 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34999}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ProPhase Labs, Inc. (id: 34999)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.